Wird geladen...
The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells
The efficient treatment of hematological malignancies as Acute Myeloid Leukemia, myelofibrosis and Chronic Myeloid Leukemia, requires the elimination of cancer-initiating cells and the prevention of disease relapse through targeting pathways that stimulate generation and maintenance of these cells....
Gespeichert in:
Veröffentlicht in: | Oncotarget |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Impact Journals LLC
2016
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342419/ https://ncbi.nlm.nih.gov/pubmed/27486815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10879 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|